Related Experiment Video
Updated: May 19, 2026

06:22
Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
Experimentally induced rodent models of type 2 diabetes
Md Shahidul Islam1, Rachel Dorothy Wilson
1Department of Biochemistry, School of Biochemistry, Genetics and Microbiology, University of KwaZulu-Natal, Durban, South Africa. islamd@ukzn.ac.za
Methods in Molecular Biology (Clifton, N.J.)
|August 16, 2012
Summary
Type 2 diabetes (T2D) research commonly uses rodent models. This review evaluates experimentally induced non-genetic models, highlighting their pros and cons for selecting the best animal model.
Area of Science:
- Endocrinology and Metabolism
- Animal Models in Biomedical Research
- Diabetology
Background:
- Type 2 diabetes (T2D) is a significant global health issue, particularly prevalent in developing nations.
- Rodents are favored animal models for diabetes research due to practical advantages.
- Experimentally induced non-genetic models are widely used for T2D research.
Purpose of the Study:
- To comparatively evaluate experimentally induced rodent models for type 2 diabetes research.
- To analyze the limitations, advantages, and disadvantages of various non-genetic T2D models.
- To guide researchers in selecting appropriate animal models for their specific research questions.
Main Methods:
- Review of established non-genetic rodent models for T2D induction.
- Comparative analysis of models including alloxan/streptozotocin (STZ), high-fat diet, and fructose-fed models.
- Evaluation of model limitations, advantages, and developmental criticality.
Main Results:
- Several non-genetic models exist, including STZ, partial pancreatectomy, high-fat diet, fructose-fed, nicotinamide-STZ, MSG, and IUGR models.
- No single model perfectly replicates all human T2D pathogenesis.
- Each model presents unique benefits and drawbacks for diabetes research.
Conclusions:
- Selecting the optimal T2D rodent model requires careful consideration of research objectives and model-specific limitations.
- Understanding the comparative strengths and weaknesses of different models is crucial for successful diabetes research.
- Further refinement of existing models or development of new ones may be necessary to better mimic human T2D.
Related Concept Videos
Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
